Your browser doesn't support javascript.
loading
Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis.
Gronda, Edoardo; Lopaschuk, Gary D; Arduini, Arduino; Santoro, Antonio; Benincasa, Giuditta; Palazzuoli, Alberto; Gabrielli, Domenico; Napoli, Claudio.
Afiliación
  • Gronda E; Dipartimento di Medicina e Specialità Mediche, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico di Milano UOC di Nefrologia, Dialisi e Trapianto Renale dell'adulto, Milan, Italy.
  • Lopaschuk GD; Cardiovascular Research Centre, University of Alberta, 423 Heritage Medical Research Centre, Edmonton, AB T6G 2S2, Canada.
  • Arduini A; Department of Research and Development, CoreQuest Sagl, Tecnopolo, 6934 Bioggio, Switzerland.
  • Santoro A; Nephrology Unit, S. Orsola-Malpighi Hospital, University of Bologna, Italy.
  • Benincasa G; Clinical Department of Internal Medicine and Specialistic Units, Azienda Ospedaliera Universitaria and Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Palazzuoli A; Cardiovascular Diseases Unit, Department of Medical Sciences, Le Scotte Hospital University of Siena, Italy.
  • Gabrielli D; Division of Cardiology, San Camillo Hospital, Rome, Italy and Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO).
  • Napoli C; Clinical Department of Internal Medicine and Specialistic Units, Azienda Ospedaliera Universitaria and Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Can J Physiol Pharmacol ; 100(2): 93-106, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35112597

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cardiotónicos / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Límite: Humans Idioma: En Revista: Can J Physiol Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cardiotónicos / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Límite: Humans Idioma: En Revista: Can J Physiol Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Italia